In February 2020, NIIMBL ran a three-day workshop, which included participants from the FDA, the U.S. National Institute of Standards and Technology, plus what Erickson describes as “distinguished leaders in manufacturing and process development from 14 major manufacturers and suppliers.”

In January 2021, a team of pharmaceutical experts...

If city leaders across the country learned anything from the past year, it's the value of resilience.

The COVID-19 pandemic exposed cracks in infrastructure , posed mobility challenges, and revealed a digital divide. The places that have fared the best are the ones that have been investing in the future, specifically in areas like digital...

The Department of Commerce’s National Institute of Standards and Technology (NIST), through the CARES Act, provided funding to the ARM Institute to collaborate with Wilder Systems to develop this technology.

The ARM Institute is leading the way to a future where people and robots work together to respond to the nation’s greatest challenges and to...

Today’s supply chains and manufacturing operations are global, highly efficient, and carefully tuned. At the same time, the COVID-19 black-swan event has demonstrated painfully that they are also fragile and lacking transparency at times when faced with unexpected disturbances. The various interruptions led to a shortage of essential goods, ranging...

Remember in-person meetings? A year ago, would you have thought our world, our homes and offices would be upended and changed so rapidly? Seemingly overnight businesses were adapting to a new reality. We at U.S. Food and Drug Administration adapted as well – we had to. Our mission is so critical, we couldn’t fall behind because too much was, and...